Monica M. Santisteban

Has grant

Vanderbilt University Medical Center
Country flagUnited States

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Role of brain angiotensin-mediated tau phosphorylation in cognitive decline in aging and hypertension

Open Date: 2023-07-01

Close Date: 2026-06-30

Grant: Close

Neuroimmune Mechanisms of Cognitive Impairment in Salt-sensitive Hypertension

Open Date: 2021-07-15

Close Date: 2023-06-30

Grant: Close

Role of brain perivascular macrophages in the cognitive dysfunction of chronic hypertension

Open Date: 2017-01-01

Close Date: 2018-12-31

Grant: Close

The involvement of microglial cell activation in the development and establishment of hypertension

Open Date: 2014-01-01

Close Date: 2015-08-11

Articles (4)

Dementia affects almost 50 million adults worldwide, and remains a major cause of death and disability. Hypertension is a leading risk factor for dementia, including Alzheimer disease and Alzheimer disease–related dementias. Although this association is well-established, the mechanisms underlying hypertension-induced cognitive decline remain poorly understood. By exploring the mechanisms mediating the detrimental effects of hypertension on the brain, studies have aimed to provide therapeutic insights and strategies on how to protect the brain from the effects of blood pressure elevation. In this review, we focus on the basic mechanisms contributing to the cerebrovascular adaptions to elevated blood pressure and hypertension-induced microvascular injury. We also assess the cellular mechanisms of neurovascular unit dysfunction, focusing on the premise that cognitive impairment ensues when the dynamic metabolic demands of neurons are not met due to neurovascular uncoupling, and summarize cognitive deficits across various rodent models of hypertension as a resource for investigators. Despite significant advances in antihypertensive therapy, hypertension remains a critical risk factor for cognitive decline, and several questions remain about the development and progression of hypertension-induced cognitive impairment.

Year:

2024

Year:

2023

Year:

2021

Year:

2020

Collaborators (2)

Daniela Carnevale

Full Professor MED/50

Sapienza University of Rome

ITALY
View details

Costantino Iadecola

Weill Cornell Medical College

UNITED STATES
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.